Back to search
FDAFDA · Food and drugs·Recall number D-1318-2014

Saluta (reduced glutathione) Powder for Injection, 600 mg/vial, packaged in 10 vials per box, Exclusively Distributed by: QAF Pharmaceuticals Inc. Philippines, Unit Unit 202 ECG Building, Multinational Avenue, Multinational Village, Parahaque City, Metro Manila Philippines; Manufactured by: Shandong Luye Pharmaceutical Co. Ltd, Yantai Shandong, PRC la Luye Pharma Subsidiary, UPC 6920425209014

Published May 21, 2014 · Recall initiated: April 29, 2014

Summary

FDA records drug Class II recall D-1318-2014, published May 21, 2014 and initiated April 29, 2014. Recalling firm: Flawless Beauty LLC; Status: Completed; Reported quantity: unknown; Lot: Lot #: 201302275, Exp 01/20/15; 201308384, Exp 10/19/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Parenteral product is labeled for use as an antidote.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Flawless Beauty LLC
Distributor
Nationwide
UPC
6920425209014
Lot
Lot #: 201302275, Exp 01/20/15; 201308384, Exp 10/19/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Saluta (reduced glutathione) Powder for Injection, 600 mg/vial, packaged in 10 vials per box, Exclusively Distributed by: QAF Pharmaceuticals Inc. Philippines, Unit Unit 202 ECG Building, Multinational Avenue, Multinational Village, Parahaque City, Metro Manila Philippines; Manufactured by: Shandong Luye Pharmaceutical Co. Ltd, Yantai Shandong, PRC la Luye Pharma Subsidiary, UPC 6920425209014 recalled?

Yes. FDA published recall D-1318-2014 on May 21, 2014. Reported hazard: Marketed Without An Approved NDA/ANDA: Parenteral product is labeled for use as an antidote.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 6920425209014.